Histologically, BMP9 significantly alleviated hepatic steatosis and hepatocyte ballooning in HFD-fed mice (Figure 3C), and the NAS was clearly decreased in BMP9-treated mice compared to untreated mice. Here, GDF2 is linked to fatty liver disease.